It is a pharma public limited company based in Hyderabad, Telangana, India, established in 1992.
1992 | Hyderabad, Telangana, India | ActiveRichline Pharma Ltd, a active public limited company, was established on 30 September 1992 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24239TG1992PLC014809. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.18 Cr.
It upholds a active non-compliant status. Its leadership includes Subba Rao Yarapotina (Director), Vijay Kumar Desa (Director), Yerapotina Sri Ramesh Babu (Director). It holds ₹1.75 Cr open charges and no settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at 8-3-977/9/3,Srinivasa Apts. Srinagar Colony,, Hyderabad, Telangana, 500073.
U24239TG1992PLC014809
014809
30 September 1992
₹5.00 Cr
₹4.18 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Richline Pharma Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subba Rao Yarapotina | Director | 30 Sep 1992 | Current |
| Vijay Kumar Desa | Director | 17 Jan 2007 | Current |
| Yerapotina Sri Ramesh Babu | Director | 30 Sep 1992 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Richline Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Richline Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹17,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jan 1996 | Canara Bank | ₹2.50 M | Open |
| 24 Oct 1995 | Canara Bank | ₹1.50 M | Open |
| 05 Oct 1995 | Canara Bank | ₹2.50 M | Open |
| 24 Aug 1994 | Canara Bank | ₹1.10 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Richline Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Richline Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Richline Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Richline Pharma Ltd last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was documented.
The activity Richline Pharma Ltd has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad. was completed.
Vijay Kumar Desa was appointed as a Director was appointed as a Director on 17 Jan 2007 & has been associated with this company since 18 years 11 months . was recorded as a recent event.
The activity A charge with Canara Bank amounted to Rs. 0.25 Cr with Charge ID 90135544 was registered on 04 Jan 1996. was completed.
Progress on A charge with Canara Bank amounted to Rs. 0.15 Cr with Charge ID 90135519 was registered on 24 Oct 1995. was documented.
A charge with Canara Bank amounted to Rs. 0.25 Cr with Charge ID 90135515 was registered on 05 Oct 1995. was recorded as a recent event.
The CIN of Richline Pharma Ltd is U24239TG1992PLC014809.
Richline Pharma Ltd is headquartered at 8-3-977/9/3,Srinivasa Apts. Srinagar Colony,, Hyderabad, Telangana, 500073.
Richline Pharma Ltd was incorporated on 30 September 1992.
The current directors of Richline Pharma Ltd are
The primary industry of Richline Pharma Ltd is Pharma.
Richline Pharma Ltd is unlisted.
The authorized capital of Richline Pharma Ltd is ₹5.00 Cr, and the paid-up capital is ₹4.18 Cr.
The compliance status of Richline Pharma Ltd is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX